Robitussin maker Haleon has agreed to pay $4.5 million to resolve claims it advertised the product as “non-drowsy” despite containing an ingredient that could cause sleepiness, TopClassAction ...

Robitussin was at the center of a class-action complaint over its “non-drowsy” cough and cold medicines. Screengrab from Calchi, et al. v. GlaxoSmithKline Consumer Healthcare Holdings (US) LLC ...